Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06513819 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

HIV and Alcohol Research Center Focused on Polypharmacy (HARP) Pilot 2 (2nd HARP Pilot Intervention)

Study acronym: HARP
StatusRecruiting
PhasePhase 1
Started2025-01-15
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 13 months later Jun 2026 → Aug 2027
See other at-risk trials from Yale University

Amendment history

2026-09-26
Primary completion pushed: 2026-06 → 2027-08
Completion pushed: 2026-06 → 2027-08
2026-01-13
Study Status v4
Primary completion date2025-12→2026-06
Completion date2025-12→2026-06
2025-01-15
Study Status v3
Start dateestimated 2025-01→confirmed 2025-01-15
2025-01-09
Not Yet Recruiting→Recruiting Study Status, Contacts/Locations v2
Trial statusNot Yet Recruiting→Recruiting
Primary completion date2025-08→2025-12
Completion date2025-08→2025-12
Start date2024-11→2025-01
Study sitesdetails revised at 1 of 1 site
2024-10-28
Study Status v1
Start date2024-08→2024-11
2024-07-15
Original filing
Yale University
487 trials monitored
See 35 trials at risk
The focus of this pilot will be on falls and neurocognitive symptoms, and the impact of alcohol, cannabis use, and medications on these outcomes. The rationale is that alcohol use at any level may interact with neurocognitively active medications, alcohol, and cannabis use leading to falls and impaired cognition.
Trial Details
NCT Number NCT06513819
Lead Sponsor Yale University
Collaborators: National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Conditions Hiv, Alcohol Drinking, Fall, Cannabis Use
Enrollment 100 participants
Start Date 2025-01-15
Primary Completion 2027-08 (estimated)
Study Completion 2027-08 (estimated)
Updated on ClinicalTrials.gov 2026-09-25